Stockscreener 앱 받기
2.42
1.22%
-0.03
시간 외 거래:
2.40
-0.02
-0.83%
Iovance Biotherapeutics Inc 주식(IOVA)의 최신 뉴스
Does Iovance Biotherapeutics Inc. qualify in momentum factor screening2025 Top Decliners & Daily Growth Stock Investment Tips - Newser
Candlestick signals on Iovance Biotherapeutics Inc. stock todayJuly 2025 Action & Weekly High Potential Alerts - Newser
Will Iovance Biotherapeutics Inc. bounce back from current support2025 Volatility Report & Community Shared Stock Ideas - Newser
How to build a custom watchlist for Iovance Biotherapeutics Inc.Trade Performance Summary & Comprehensive Market Scan Reports - Newser
Is this a good reentry point in Iovance Biotherapeutics Inc.Weekly Profit Recap & Daily Volume Surge Signals - Newser
Iovance Biotherapeutics: Is the Stock's Plunge a Buying Opportunity or a Warning Sign? - AInvest
Iovance: Thin Margins, Dilution Threat Keep Risk-Skewed (NASDAQ:IOVA) - Seeking Alpha
Risk vs reward if holding onto Iovance Biotherapeutics Inc.Long Setup & Accurate Technical Buy Alerts - Newser
Can momentum traders help lift Iovance Biotherapeutics Inc.2025 Earnings Surprises & Capital Efficiency Focused Strategies - Newser
Visualizing Iovance Biotherapeutics Inc. stock with heatmapsJuly 2025 PreEarnings & Accurate Intraday Trade Tips - Newser
Key resistance and support levels for Iovance Biotherapeutics Inc.2025 Earnings Surprises & Stepwise Trade Signal Implementation - Newser
Will breakout in Iovance Biotherapeutics Inc. lead to full recovery2025 Biggest Moves & AI Powered Buy/Sell Recommendations - Newser
Is Iovance Biotherapeutics Inc. a candidate for recovery playPortfolio Value Summary & Growth Focused Stock Pick Reports - Newser
Is Iovance Biotherapeutics Inc. forming a bottoming baseJuly 2025 Highlights & AI Based Buy/Sell Signal Reports - Newser
Multi factor analysis applied to Iovance Biotherapeutics Inc.July 2025 Reactions & Free Safe Capital Growth Stock Tips - Newser
How to monitor Iovance Biotherapeutics Inc. with trend dashboardsWeekly Trade Review & Fast Moving Stock Trade Plans - Newser
Will Iovance Biotherapeutics Inc. continue its uptrend2025 Market Trends & Weekly Watchlist for Hot Stocks - Newser
Combining machine learning predictions for Iovance Biotherapeutics Inc.July 2025 PreEarnings & Long Hold Capital Preservation Plans - Newser
How to forecast Iovance Biotherapeutics Inc. trends using time seriesWeekly Trade Recap & Risk Controlled Swing Alerts - Newser
What to do if you’re stuck in Iovance Biotherapeutics Inc.Rate Cut & Low Risk Growth Stock Ideas - Newser
Iovance Biotherapeutics Inc. stock daily chart insightsDollar Strength & Community Driven Trade Alerts - Newser
Untreated Metastatic or Unresectable Melanoma Clinical Trial Pipeline Expands as 10+ Companies Driving Innovation in Oncology Therapeutics Space | DelveInsight - GlobeNewswire Inc.
Can Iovance Biotherapeutics Inc. rally from current levelsJuly 2025 Institutional & Expert Approved Trade Ideas - Newser
Iovance Biotherapeutics Secondary Stock Offering: A $350M Deal with a 6% Share Price Drop - AInvest
IOVA Stock Drops 6% on $350M Common Stock Offering - TradingView
Building trade automation scripts for Iovance Biotherapeutics Inc.Recession Risk & Long-Term Safe Investment Plans - Newser
Reversal indicators forming on Iovance Biotherapeutics Inc. stockBear Alert & Community Trade Idea Sharing - Newser
Will Iovance Biotherapeutics Inc. benefit from macro trendsJuly 2025 Highlights & AI Driven Price Predictions - Newser
Chart based analysis of Iovance Biotherapeutics Inc. trendsExit Point & AI Powered Buy/Sell Recommendations - Newser
Is Iovance Biotherapeutics Stock Due for a Big Rally? - MSN
Why Iovance Biotherapeutics Stock Got Mashed on Monday - AOL.com
Artisan Small Cap Fund Exited Its Stake in Iovance Biotherapeutics (IOVA) Due to Operational Challenges - Insider Monkey
Iovance Biotherapeutics Grants Stock Options to New Employees Under NASDAQ Listing Rule 5635(c)(4) - AInvest
1 Beaten-Down Stock That Could Soar By 261%, According to Wall Street - AOL.com
Price momentum metrics for Iovance Biotherapeutics Inc. explainedJuly 2025 Drop Watch & AI Powered Market Entry Strategies - Newser
Is Iovance Biotherapeutics Inc. stock entering bullish territoryStop Loss & Stepwise Swing Trade Plans - Newser
Iovance Biotherapeutics (IOVA) Receives Conditional Approval From Health Canada - MSN
Iovance Biotherapeutics' $350M ATM Financing: A High-Stakes Bet on Amtagvi's Future - AInvest
Iovance Biotherapeutics Amends Sale Agreement with Jefferies - TipRanks
Iovance Biotherapeutics Grants Inducement Stock Options to New Employees - Quiver Quantitative
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire
How to escape a deep drawdown in Iovance Biotherapeutics Inc.Analyst Downgrade & Fast Entry High Yield Stock Tips - Newser
Iovance Biotherapeutics: Navigating the High-Risk, High-Reward Path of Amtagvi Global Expansion - AInvest
Iovance Biotherapeutics: Tough Decisions Being Made But Catalysts In H2'25 (NASDAQ:IOVA) - Seeking Alpha
0.98%
8.06%
자본화:
|
볼륨(24시간):